A Study to Evaluate the Efficacy, Safety and Tolerability of Fixed Doses of Intranasal Esketamine in Japanese Participants With Treatment Resistant Depression
Clinical trial NCT02918318 · COMPLETED
Trial details
- NCT number
- NCT02918318
- Sponsor
- Janssen Pharmaceutical K.K.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-12
- Primary completion
- 2019-08-19
- Enrollment
- 202
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.